查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847912

疫苗管瓶监测器市场按类型、材料、管瓶规格、疫苗种类和最终用户划分－2025-2032年全球预测

Vaccine Vial Monitor Market by Type, Material, Vial Size, Vaccine, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，疫苗管瓶监测器市场规模将达到 14.9403 亿美元，复合年增长率为 23.53%。

主要市场统计数据
基准年 2024 2.7538亿美元
预计年份：2025年 3.4161亿美元
预测年份：2032年 1,494,030,000 美元
复合年增长率 (%) 23.53%

权威概述疫苗管瓶监测技术，这些技术支持低温运输完整性并提高不同供应环境下免疫接种计划的可靠性

疫苗管瓶温度监测器 (VVM) 在保障免疫规划中发挥着至关重要的作用，它能够可靠、直观地显示温度敏感型疫苗的累积受热情况。无论固定在管瓶上或整合在包装中，这些装置都能减少浪费、提高疫苗接种安全性，并帮助第一线工作负责人就疫苗的处置或使用做出明智的决定，从而增强人们对免疫宣传活动的信心。近年来，VVM 解决方案已从简单的色彩变化指示器发展成为更广泛的低温运输保障系统的组成部分，并与品管通讯协定、采购流程和医护人员培训课程整合。

因此，製造商、采购机构和公共卫生组织越来越关注疫苗瓶监测器（VVM）的耐用性、与各种疫苗配方的材料相容性，以及在诊所、医院和推广场所部署时的操作人体工学。同时，监管要求和指导方针也日益严格，强调可追溯性、标准化以及与免疫接种计划的一致性。随着新型疫苗的推出和推广宣传活动的开展，免疫接种格局日益多元化，VVM 仍然是维持疫苗效力、实现负责任的库存轮换以及支持公平获取疫苗项目目标的关键工具。所有这些因素累积促使人们更加重视能够满足现代扩大免疫接种和紧急应变行动实际情况的、针对特定环境的 VVM 解决方案。

技术进步、永续性优先事项和疫情期间的营运经验如何改变疫苗管瓶监测器的开发和采购

疫苗管瓶监测领域正经历一系列变革时期的驱动力包括技术创新、供应链重组以及不断变化的专案需求。新一代指示器越来越多地整合了资料收集点，从而支援检验工作流程和数位化记录，增强了课责和部署后分析能力。同时，材料科学的进步提高了指示器的热敏感性和环境稳定性，并增强了其与多管瓶和单剂量管瓶的兼容性，使其能够适用于更广泛的疫苗配方。

在营运方面，永续性和生命週期考量日益重要，製造商正在评估可回收基材和低毒油墨。采购者现在优先考虑整体拥有成本、培训便利性以及减少疫苗浪费的指标。从疫情期间的大规模疫苗宣传活动中汲取的经验教训，加速了人们对快速扩展、标准化培训模组以及可在资源受限环境中部署的解决方案的关注。总而言之，这些变化正在重塑产品蓝图和伙伴关係模式，促进连接指示技术、低温运输物流、数位健康平台等领域的合作，从而建立一个更具韧性和反应能力的疫苗接种系统。

深入分析 2025 年关税调整如何改变了疫苗管瓶监测供应链的采购动态、供应商策略和成本结构。

到2025年，美国关税政策的发展对疫苗管瓶监测器的供应链和采购经济产生了累积影响，波及原料成本、零件采购选择以及生产能力的地理分布。进口聚合物薄膜、特殊黏合剂和某些印刷电子元件的关税提高了部分采购管道关键投入品的到岸成本，促使采购团队和製造商重新评估其供应商组合併重新谈判条款以缓解利润压力。因此，供应商多元化和近岸外包策略已成为一种显着趋势，旨在降低关税波动和运输中断带来的风险。

为应对这一变化，一些製造商增加了在地采购或将部分生产转移到关税优惠地区，而另一些製造商则投资于流程效率提升，以在不影响产品品质的前提下消化不断上涨的投入成本。此外，由于买家实施了更严格的实质审查流程来评估关税相关风险、供应连续性和合规义务，采购週期也随之延长。在此期间，买卖双方越来越多地使用合约条款来分配关税风险，并与海关顾问加强合作，以优化关税分类协调。总而言之，这些调整增强了企业的韧性，但也增加了采购计画的复杂性，影响了前置作业时间、价格谈判、库存缓衝和供应商冗余等方面的策略决策。

深入的細項分析表明，类型、材质、管瓶规格、疫苗类别和最终用户画像如何决定管瓶监测器的设计和采购优先顺序。

细分市场层面的动态揭示了不同产品类型、材料、管瓶规格、疫苗类别和终端用户环境的优先事项和技术要求，这些因素反过来又会影响设计、法规遵循和采购选择。按类型划分，市场研究涵盖了I型、II型、III型和IV型指示剂，每种类型都有不同的热响应特性和应用方式，以适应特定的低温运输场景和疫苗处理通讯协定。薄膜型指示器强调低体积整合和强附着力，涂料型解决方案强调持久耐用的直接标记，而贴纸型指示剂则优先考虑可方便地适配各种管瓶规格。根据管瓶规格，指示剂可分为多剂量指示剂和单剂量指示剂。多剂量管瓶通常需要能够承受反覆操作和各种暴露环境的指示器，而单剂量药瓶则可能优先考虑紧凑性和低材料占用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合物联网技术的管瓶监测器可提高低温运输的可视性和合规性。
  • 引入比色连续温度监测技术以减少农村地区的疫苗浪费
  • 促进制定世界卫生组织关于疫苗管瓶监测器准确性和保质期指标的标准
  • 开发智慧标籤技术，可在运输过程中即时预警温度偏差
  • 管瓶监测器製造商与物流供应商之间的合作提高了最后一公里配送的可靠性
  • 整合疫苗管瓶监测器的数位资料记录器的需求不断增长，以便进行集中追踪
  • 太阳能低温运输解决方案与偏远地区管瓶监测器整合应用的影响

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 疫苗管瓶监测器市场（按类型划分）

  • 一型
  • II 型
  • III型
  • 四型

9. 依材料分類的疫苗管瓶监测器市场

  • 电影
  • 画
  • 贴纸

第十章 依管瓶尺寸分類的疫苗管瓶监测市场

  • 多次给药
  • 单一剂量

第十一章 疫苗管瓶监测市场（依疫苗分类）

  • 白喉、百日咳、破伤风
    • 白喉
    • 百日咳
    • 破伤风
  • 麻疹
  • 脊髓灰质炎
  • 破伤风

第十二章 疫苗管瓶监测器市场（依最终用户划分）

  • 诊所
  • 医院
  • 疫苗接种中心

第十三章 疫苗管瓶监测器市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 疫苗管瓶监测器市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国疫苗管瓶监测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Nipro Corporation
    • Gerresheimer AG
    • EVIGENCE SENSORS Inc.
    • Zebra Technologies Corp.
    • Cardinal Health, Inc.
    • ELPRO-BUCHS AG
    • Berlinger & Co. AG
    • Lisaline Lifescience Technologies Pvt Ltd
    • Avantor
    • Thermo Fisher Scientific Inc.
Product Code: MRR-FB6C9E792F4C

The Vaccine Vial Monitor Market is projected to grow by USD 1,494.03 million at a CAGR of 23.53% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 275.38 million
Estimated Year [2025] USD 341.61 million
Forecast Year [2032] USD 1,494.03 million
CAGR (%) 23.53%

An authoritative overview of how vaccine vial monitoring technologies underpin cold-chain integrity and strengthen immunization program reliability across diverse delivery settings

Vaccine vial monitors (VVMs) play a pivotal role in protecting immunization programs by providing a visible, reliable indication of cumulative heat exposure for temperature-sensitive vaccines. These devices, whether affixed on a vial or integrated into packaging, reduce wastage, increase the safety of vaccine administration, and support trust in immunization campaigns by enabling frontline personnel to make informed discard-or-use decisions. Over recent years, VVM solutions have evolved from simple colour-change indicators to components of a broader cold-chain assurance ecosystem, integrating with quality-control protocols, procurement practices, and training curricula for healthcare workers.

Consequently, manufacturers, procurement agencies, and public health organizations have sharpened their focus on durability, material compatibility with different vaccine formulations, and the operational ergonomics of deployment across clinic, hospital, and outreach settings. This has been accompanied by increasingly stringent regulatory expectations and guidance emphasizing traceability, standardization, and compatibility with immunization schedules. As the immunization landscape diversifies with new vaccine presentations and increased outreach campaigns, VVMs remain a foundational tool to maintain vaccine potency, enable responsible inventory turnover, and support programmatic goals for equitable access. The cumulative effect is a renewed emphasis on fit-for-context VVM solutions that align with the realities of modern expanded immunization efforts and emergency response operations.

How technological advances, sustainability priorities, and pandemic-era operational lessons are reshaping vaccine vial monitor development and procurement practices

The landscape for vaccine vial monitors is undergoing a set of transformative shifts driven by technological innovation, supply-chain realignment, and evolving programmatic needs. Digital augmentation is emerging as a defining trend: next-generation indicators are increasingly designed with integration points for data capture, enabling verification workflows and digital recordkeeping that bolster accountability and post-deployment analytics. At the same time, materials science advances are refining the thermal sensitivity and environmental robustness of indicators, improving compatibility across multi-dose and single-dose vials and for a wider range of vaccine formulations.

Operationally, there is growing emphasis on sustainability and lifecycle considerations, prompting manufacturers to evaluate recyclable substrates and lower-toxicity inks. Procurement practices are likewise changing; buyers now weigh total cost of ownership, ease of training, and the indicator's contribution to reducing vaccine wastage. Lessons learned from pandemic-era mass immunization campaigns have accelerated attention to rapid scalability, standardized training modules, and the need for deployable solutions in resource-constrained environments. Taken together, these shifts are reshaping product roadmaps and partnership models, encouraging collaborations that bridge indicator technology, cold-chain logistics, and digital health platforms to deliver more resilient and responsive immunization systems.

An in-depth exploration of how tariff adjustments through 2025 altered sourcing dynamics, supplier strategies, and cost structures for vaccine vial monitor supply chains

United States tariff policy developments through 2025 have exerted a cumulative influence on the supply chains and sourcing economics relevant to vaccine vial monitors, affecting raw material costs, component sourcing choices, and the geographic distribution of manufacturing capacity. Tariffs on imported polymer films, specialty adhesives, and certain printed electronic components have raised the landed cost of key inputs in some sourcing corridors, prompting procurement teams and manufacturers to reassess supplier portfolios and renegotiate terms to mitigate margin pressure. As a result, there has been a discernible shift toward supplier diversification and nearshoring strategies intended to reduce exposure to tariff volatility and shipping disruptions.

In response, some manufacturers have increased local sourcing or relocated portions of production to tariff-favored jurisdictions, while others invested in process efficiencies to absorb incremental input costs without compromising performance. Moreover, procurement cycles have extended as buyers instituted more robust due-diligence processes to evaluate tariff-related risks, supply continuity, and compliance obligations. This period also saw greater use of contract clauses that allocate tariff risk between buyers and suppliers, and increased collaboration with customs advisors to optimize harmonized tariff classifications. Collectively, these adjustments improved resilience but also introduced complexity into procurement planning, influencing lead times, pricing negotiations, and strategic decisions around inventory buffers and supplier redundancy.

Insightful segmentation analysis showing how type, material, vial size, vaccine category, and end-user profiles determine design and procurement priorities for vial monitors

Segment-level dynamics reveal differentiated priorities and technical requirements across product types, materials, vial sizes, vaccine categories, and end-user settings, which in turn inform design, regulatory conformity, and procurement choices. Based on Type, market studies span Type I, Type II, Type III, and Type IV indicators, each offering distinct thermal response profiles and application modalities that suit particular cold-chain scenarios and vaccine handling protocols. Based on Material, analyses cover Film, Paint, and Sticker formats; film-based indicators emphasize low-bulk integration and robust adhesion, paint-based solutions focus on durable direct marking, and sticker formats prioritize retrofittable convenience for diverse vial geometries. Based on Vial Size, attention differentiates between Multi Dose and Single Dose presentations, as multi-dose vials often require indicators tolerant of repeated handling and varying exposure profiles, whereas single-dose formats may prioritize compactness and low material footprint.

Based on Vaccine, scrutiny extends to DPT, Measles, Polio, and Tetanus categories, with DPT further disaggregated into Diphtheria, Pertussis, and Tetanus to reflect differing temperature sensitivities and programmatic schedules that influence indicator selection and labeling requirements. Based on End User, use-case distinctions among Clinics, Hospitals, and Vaccination Centers drive preferences for indicator robustness, user-training burden, and compatibility with outbreak-response workflows. Taken together, these segmentation lenses illuminate where innovation, cost-optimization, and targeted education can most effectively reduce vaccine loss and enhance cold-chain fidelity across the immunization continuum.

Regional dynamics and procurement realities that determine which vial monitoring solutions deliver durability, affordability, and integration across diverse health systems

Regional dynamics affect procurement strategies, regulatory expectations, and supply-chain resilience in materially different ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific, shaping both demand patterns and the logistical constraints that influence product selection. In the Americas, procurement tends to favor standards-compliant solutions with a focus on integration into established cold-chain networks and electronic health record systems, while regulatory bodies emphasize traceability and standardized testing protocols that align with continental and national immunization policies. Transitioning to Europe, Middle East & Africa, stakeholders navigate a complex mosaic of regulatory frameworks and infrastructure maturity levels; in this diverse region, scalable, low-complexity indicators that can perform reliably in low-resource and high-temperature environments are particularly valued, and procurement often incorporates considerations for large-scale campaign logistics and donor-funded program requirements.

In the Asia-Pacific region, the interplay of large urban centers and remote outreach operations drives demand for both highly automated indicator solutions in tertiary care settings and rugged, low-cost formats for community-level deployment. The region's manufacturing capacity and proximity to major polymer-film and adhesive suppliers also influence lead-time expectations and cost structures, prompting regional procurement agencies to balance responsiveness with long-term supplier relationships. Across all regions, harmonization efforts, interoperability with digital health initiatives, and locally tailored training materials remain critical to maximizing the utility of vial monitoring technologies in supporting immunization goals.

How manufacturers and suppliers are aligning R&D, manufacturing footprint decisions, and collaborative partnerships to gain competitive resilience and field relevance

Commercial strategies among leading manufacturers and suppliers reflect a balance of product innovation, geographic footprint management, and partnership-building to meet the operational realities of immunization programs. Many companies are investing in R&D to improve indicator sensitivity and broaden compatibility with emerging vaccine formulations while protecting proprietary processes through targeted intellectual property and quality-management systems. At the same time, suppliers are optimizing production networks to reduce tariff exposure and shipping lead times, establishing regional manufacturing nodes and qualified contract manufacturing partnerships to support large-scale campaigns.

Strategic collaborations with cold-chain logistics providers, digital health vendors, and public-sector procurement agencies are increasing, enabling bundled offerings that combine physical indicators with training, data capture, and verification services. Pricing strategies have become more nuanced, with tiered product lines that address high-performance institutional buyers and cost-sensitive public-health customers. Additionally, companies are prioritizing certification and compliance to meet the varied regulatory requirements across jurisdictions, while some are pursuing selective acquisitions to expand material expertise or distribution channels. The net effect is a competitive landscape where differentiation arises from the ability to deliver dependable performance, streamlined logistics, and services that reduce the complexity of field deployment for immunization partners.

Actionable strategic measures that suppliers, procurement teams, and health program leaders can implement now to strengthen supply chains, product adoption, and sustainability

Industry leaders should adopt a pragmatic, multi-pronged approach to secure resilient supply chains, improve product fit, and support programmatic adoption. First, prioritize supplier diversification and contractual mechanisms that share tariff risk, and concurrently evaluate nearshoring options for critical raw materials to reduce exposure to tariff-induced disruptions and shipping volatility. Second, invest in product modularity and variant portfolios that allow rapid configuration between film, paint, and sticker formats and between multi-dose and single-dose applications to meet diverse end-user requirements without extensive retooling. Third, deepen collaborations with digital-health integrators to create optional data-capture pathways that enhance discard decision audits and strengthen vaccine stewardship without imposing heavy operational burdens on frontline staff.

Fourth, accelerate workforce training and pragmatic job aids tailored for clinics, hospitals, and centralized vaccination centers to ensure correct interpretation and consistent use of indicators during routine immunization and surge campaigns. Fifth, engage with regulatory authorities early to streamline conformity testing and labeling across jurisdictions, and leverage pooled procurement or framework agreements where appropriate to stabilize demand and improve negotiating leverage. Finally, incorporate sustainability metrics into procurement decisions, piloting recyclable or lower-impact materials while monitoring durability and adhesion performance, so that environmental objectives advance in parallel with programmatic reliability.

A transparent and reproducible mixed-methods research process combining stakeholder interviews, standards review, and supply-chain risk profiling to support operational decision-making

This research synthesized qualitative and quantitative inputs through a structured, replicable methodology designed to ensure data integrity and applicability for operational decision-makers. Primary data collection comprised semi-structured interviews with a cross-section of stakeholders including manufacturing engineers, procurement leads at immunization programs, vaccine program managers, logistics specialists, and clinical end users; interviews were designed to surface practical constraints, adoption barriers, and innovation priorities. Secondary inputs were gathered from publicly available regulatory guidance, technical standards documents, manufacturer disclosures, trade and customs data, and peer-reviewed literature to contextualize operational practices and material science developments.

The analytical approach combined comparative feature mapping across product types and materials, supply-chain risk profiling that considered tariff and logistics exposures, and regionally differentiated use-case assessments calibrated to clinic, hospital, and vaccination-center workflows. Data validation steps included triangulation across independent sources, follow-up verification with subject-matter experts, and scenario-based stress-testing of supplier continuity assumptions. Throughout, emphasis was placed on transparent documentation of assumptions, clear delineation of data provenance, and an iterative review cycle with domain experts to confirm technical accuracy and relevance to procurement and deployment decisions.

A concise synthesis of evidence-based conclusions emphasizing practical pathways to reduce vaccine wastage, improve reliability, and strengthen program outcomes

In conclusion, vaccine vial monitors remain an indispensable element of immunization program integrity, and their continued evolution is shaped by technological advances, supply-chain recalibrations, and diverse regional requirements. Stakeholders benefit from aligning product specifications with the realities of end-user settings-whether that means rugged, low-complexity indicators for outreach campaigns or integrated solutions that support digital verification in institutional settings. Tariff developments through 2025 have underscored the importance of proactive supplier management and manufacturing flexibility, prompting strategic shifts that enhance resilience but require careful operational planning.

Looking forward, the greatest opportunities lie in converging durable materials science with pragmatic digital enablement, in fostering public-private partnerships that reduce deployment friction, and in embedding sustainability and lifecycle thinking into procurement decisions. By adopting the targeted recommendations outlined above-spanning supplier strategy, product modularity, regulatory engagement, and end-user training-industry participants can reduce vaccine wastage, improve program confidence, and better support the expanded immunization efforts that public health systems are undertaking worldwide. The evidence supports a deliberate, collaborative approach to innovation and procurement that prioritizes reliability, affordability, and ease of use.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of IoT enabled vial monitors to improve cold chain visibility and compliance
  • 5.2. Adoption of colorimetric continuous temperature monitoring to reduce vaccine wastage in rural areas
  • 5.3. Regulatory push for WHO standards on vaccine vial monitor accuracy and shelf life indicators
  • 5.4. Development of smart label technologies with real time alerts for temperature excursions during transit
  • 5.5. Collaboration between vial monitor manufacturers and logistics providers to enhance last mile delivery reliability
  • 5.6. Growth in demand for digital data loggers integrated with vaccine vial monitors for centralized tracking
  • 5.7. Impact of solar powered cold chain solutions integrated with vial monitors in remote regions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vaccine Vial Monitor Market, by Type

  • 8.1. Type I
  • 8.2. Type II
  • 8.3. Type III
  • 8.4. Type IV

9. Vaccine Vial Monitor Market, by Material

  • 9.1. Film
  • 9.2. Paint
  • 9.3. Sticker

10. Vaccine Vial Monitor Market, by Vial Size

  • 10.1. Multi Dose
  • 10.2. Single Dose

11. Vaccine Vial Monitor Market, by Vaccine

  • 11.1. DPT
    • 11.1.1. Diphtheria
    • 11.1.2. Pertussis
    • 11.1.3. Tetanus
  • 11.2. Measles
  • 11.3. Polio
  • 11.4. Tetanus

12. Vaccine Vial Monitor Market, by End User

  • 12.1. Clinics
  • 12.2. Hospitals
  • 12.3. Vaccination Centers

13. Vaccine Vial Monitor Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Vaccine Vial Monitor Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Vaccine Vial Monitor Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Nipro Corporation
    • 16.3.2. Gerresheimer AG
    • 16.3.3. EVIGENCE SENSORS Inc.
    • 16.3.4. Zebra Technologies Corp.
    • 16.3.5. Cardinal Health, Inc.
    • 16.3.6. ELPRO-BUCHS AG
    • 16.3.7. Berlinger & Co. AG
    • 16.3.8. Lisaline Lifescience Technologies Pvt Ltd
    • 16.3.9. Avantor
    • 16.3.10. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VACCINE VIAL MONITOR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE I, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE I, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE I, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE I, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE I, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE I, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE II, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE II, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE II, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE II, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE II, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE II, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE III, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE III, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE III, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE III, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE III, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE III, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE IV, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE IV, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE IV, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE IV, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE IV, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE IV, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY FILM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY FILM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY FILM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY FILM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY FILM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY FILM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PAINT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PAINT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PAINT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PAINT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PAINT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PAINT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY STICKER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY STICKER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY STICKER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY STICKER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY STICKER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY STICKER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DPT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DIPHTHERIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DIPHTHERIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DIPHTHERIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DIPHTHERIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DIPHTHERIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY DIPHTHERIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PERTUSSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PERTUSSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PERTUSSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PERTUSSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PERTUSSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PERTUSSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MEASLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MEASLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MEASLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MEASLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MEASLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MEASLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY POLIO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY POLIO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY POLIO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY POLIO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY POLIO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY POLIO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TETANUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY VACCINATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. GCC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GCC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GCC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. GCC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. GCC VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. GCC VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. GCC VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 268. GCC VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 272. GCC VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 273. GCC VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. GCC VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. G7 VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. G7 VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. G7 VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. G7 VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. G7 VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 308. G7 VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 309. G7 VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 310. G7 VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 311. G7 VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 312. G7 VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 313. G7 VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 314. G7 VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 315. G7 VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. G7 VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. NATO VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. NATO VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. NATO VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. NATO VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. NATO VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 322. NATO VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 323. NATO VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 324. NATO VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 325. NATO VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 326. NATO VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 327. NATO VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 328. NATO VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 329. NATO VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 330. NATO VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 331. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 337. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 339. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)
  • TABLE 341. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY DPT, 2025-2032 (USD MILLION)
  • TABLE 343. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 345. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 348. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 349. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2018-2024 (USD MILLION)
  • TABLE 350. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY VIAL SIZE, 2025-2032 (USD MILLION)
  • TABLE 351. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
  • TABLE 352. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY VACCINE, 2025-2032 (USD MILLION)